Skip to content

Advertisement

  • Oral presentation
  • Open Access

The actions of BAFF in B-lymphocyte maturation and its effects on the development of autoimmune disease

  • 1
Arthritis Res Ther20035 (Suppl 3) :16

https://doi.org/10.1186/ar817

  • Published:

Keywords

  • Public Health
  • Tumor Necrosis
  • Tumor Necrosis Factor
  • Autoimmune Disease
  • Elevate Level

BAFF, a member of the family of tumor necrosis factor ligands, is essential for the development of peripheral, mature, long-lived B lymphocytes. It binds to three different receptors (BCMA, TACI and BAFF-R), which are all members of the family of tumor necrosis factor receptors. Defects in the genes encoding either BAFF or BAFF-R abolish the generation of mature B cells. BAFF is made by myeloid cells while BAFF-R is expressed preferentially on B cells. BAFF induces polyclonal maturation of resting, short-lived immature cells to resting, long-lived mature B cells without proliferation. Lupus erythematodes-prone mice have elevated levels of BAFF in their blood, and treatment of these mice with BAFF decoy receptor (BCMA-Ig) prevents the onset of this autoimmune disease. Human lupus patients also show elevated levels of BAFF in their blood. Treatments with BAFF-neutralizing agents should prevent, delay or, at least, slow down the disease.

Authors’ Affiliations

(1)
Department of Cell Biology, Biozentrum of the University of Basel, Basel, Switzerland

Copyright

© The Author(s) 2003

Advertisement